Deleted tweets for Administration Official Scott Gottlieb, R-D.C. (Page 165)

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @RAPSorg: .@FDAcdrhIndustry Launches New 510(k) Pilot Program for Certain Ophthalmic Devices | #Regulatory Focus… https://t.co/6auoKAayy7

Deleted after 60 weeks at 12:14 PM on 18 Dec 19. Original tweet by @RAPSorg.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @AdamCMMi: (1/2) Echoing @SecAzar, the Maternal Opioid Misuse (MOM) Model addresses fragmented care delivery for pregnant & po… https://t.co/1Na5aAJuIs

Deleted after 60 weeks at 12:14 PM on 18 Dec 19. Original tweet by @AdamCMMi.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @MDMagazine: "We look forward to this important discussion on ways to make #naloxone more available to treat opioid overdose. An… https://t.co/tTvQofYELK

Deleted after 60 weeks at 12:14 PM on 18 Dec 19. Original tweet by @MDMagazine.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @FDAWomen: Medicines can affect people differently. That’s why it’s important for women of diverse backgrounds to join clinica… https://t.co/bNYlrEKBMk

Deleted after 60 weeks at 12:14 PM on 18 Dec 19. Original tweet by @FDAWomen.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @FDASpox: REPORTERS: #FDA approved the 1st new antiviral flu treatment w/ a novel mechanism of action approved by FDA in ~ 20… https://t.co/nj246oIqxn

Deleted after 60 weeks at 12:14 PM on 18 Dec 19. Original tweet by @FDASpox.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @jonathanrockoff: New flu antiviral, Xofluza from Shionogi, gets green light from @US_FDA : https://t.co/Ifkz23M786 Drug has new mech… https://t.co/R4zBUyUFdN

Deleted after 60 weeks at 12:14 PM on 18 Dec 19. Original tweet by @jonathanrockoff.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

Or whether you were taking the long view in magnifying your readers’ focus to my spectacle. QT @ikeswetlitz: I suppose only time will tell if my attention to this was short-sighted. https://t.co/RaPWtw156M)

Deleted after 59 weeks at 12:14 PM on 18 Dec 19.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @statnews: The @US_FDA has approved a #flu drug that appears to shut down infection quickly and, unlike anything else on the m… https://t.co/m3uZi4DGW8

Deleted after 59 weeks at 12:14 PM on 18 Dec 19. Original tweet by @statnews.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @MedResJourno: FDA will issue a new platform in a couple weeks to focus on digital health tools in the drug delivery system,… https://t.co/6RmqRNfWhQ

Deleted after 59 weeks at 12:14 PM on 18 Dec 19. Original tweet by @MedResJourno.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

We’re optimistic @theNASEM work will result in new, data-driven guidelines from medical professional societies to decrease unnecessary/inappropriate exposure to opioids while ensuring appropriate treatment for patients with medical need: https://t.co/1QteNyxXvl

Deleted after 59 weeks at 12:14 PM on 18 Dec 19.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

As part of a new effort with #FDA, @theNASEM will be holding the kickoff meeting next month to advance the development of evidence-based, indication-specific guidelines to help guide appropriate prescribing of opioid analgesics: https://t.co/flBipEMlox

Deleted after 59 weeks at 12:14 PM on 18 Dec 19.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

#FDA NEWS: Today #FDA approved a new antiviral flu treatment—the 1st flu treatment with a novel mechanism of action approved by FDA in ~20 yrs. With thousands in the U.S. who get the flu every year, having safe and effective treatment options is critical. https://t.co/zmSEpI1PAD https://t.co/tXZTFEiaIr

Deleted after 59 weeks at 12:14 PM on 18 Dec 19.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

#FDAs approval of a new drug to treat acute, uncomplicated flu provides an important, additional treatment option to the thousands of people who will get the #flu every year. Although there’s a new flu treatment, the best way to fight flu is by vaccination https://t.co/zmSEpI1PAD https://t.co/h9jK1ddHnf

Deleted after 59 weeks at 12:14 PM on 18 Dec 19.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @NYTHealth: The F.D.A. has approved a new flu drug, the first in 20 years to work in a new way -- so it should be effective aga… https://t.co/9uWMxebZuR

Deleted after 59 weeks at 12:14 PM on 18 Dec 19. Original tweet by @NYTHealth.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @FDA_Drug_Info: #FDAapproves new drug to treat influenza: https://t.co/3entnYURg4. https://t.co/qJeEcxJZvO

Deleted after 59 weeks at 12:14 PM on 18 Dec 19. Original tweet by @FDA_Drug_Info.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @ASHPOfficial: FDA Commissioner Scott Gottlieb shares the agency’s efforts to advance new ways to increase the availability of… https://t.co/6vfiBXarx6

Deleted after 59 weeks at 12:14 PM on 18 Dec 19. Original tweet by @ASHPOfficial.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

#FDA’s policies to expand competition and access are focused on generic drugs, but also novel innovation. We’re taking new steps to make it more efficient for innovators to bring second to market discoveries to patients to increase price competition, access, therapeutic diversity https://t.co/QfjcoRwCQI

Deleted after 59 weeks at 12:14 PM on 18 Dec 19.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

RT @SGottliebFDA: GOALS FOR 2019: Among other new steps to promote more drug competition, the #FDA is advancing a new framework for t… https://t.co/Dicf9kvoLa

Deleted after 59 weeks at 12:14 PM on 18 Dec 19. Original tweet by @SGottliebFDA.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

We have evidence that second-to-market competition is reaching patients more slowly - if it reaches them at all - when it comes to drugs targeting rarer diseases. This reduced competition is a factor in rising drug costs, and challenges patients face accessing critical medicines.

Deleted after 59 weeks at 12:14 PM on 18 Dec 19.

SteveFDA (R-D.C.)
@SGottliebFDA

Politwoops no longer follows this account.

Addressing these challenges - by modernizing our regulatory process and advancing more efficient, and scientifically rigorous approaches to developing targeted medicines - is going to be a key element of our policies to expand competition and promote access in 2019.

Deleted after 59 weeks at 12:14 PM on 18 Dec 19.

Deleted Tweets From Scott Gottlieb, R-D.C.

Results per page